Publication
Title
Vaccines and routine immunization strategies during the COVID-19 pandemic
Author
Abstract
Severe acute respiratory syndrome coronavirus 2 related disease (COVID-19) is now responsible for one of the most challenging and concerning pandemics. By August 2020, there were almost 20 million confirmed cases worldwide and well over half-million deaths. Since there is still no effective treatment or vaccine, non-pharmaceutical interventions have been implemented in an attempt to contain the spread of the virus. During times of quarantine, immunization practices in all age groups, especially routine childhood vaccines, have also been interrupted, delayed, re-organized, or completely suspended. Numerous high-income as well as low- and middle-income countries are now experiencing a rapid decline in childhood immunization coverage rates. We will, inevitably, see serious consequences related to suboptimal control of vaccine-preventable diseases (VPDs) in children concurrent with or following the pandemic. Routine pediatric immunizations of individual children at clinics, mass vaccination campaigns, and surveillance for VPDs must continue as much as possible during pandemic.
Language
English
Source (journal)
Human vaccines & immunotherapeutics. - Philadelphia, Pa, 2012, currens
Publication
Philadelphia : Taylor & francis inc , 2020
ISSN
2164-5515 [print]
2164-554X [online]
DOI
10.1080/21645515.2020.1804776
Volume/pages
p. 1-8
ISI
000562822500001
Pubmed ID
32845739
Full text (Publisher's DOI)
Full text (publisher's version - intranet only)
UAntwerpen
Faculty/Department
Research group
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Web of Science
Record
Identifier
Creation 19.10.2020
Last edited 04.12.2024
To cite this reference